Eastern Biotech introduces home testing kits for predictive genetic test in the Middle East

Eastern Biotech & Life Sciences became one of the corporate client entities of DuBiotech in November 2005. Its vision is to promote the health of the people of the United Arab Emirates and the region through the introduction of biotechnological products and systems, and through research into the diseases relevant to this region, especially genetic disorders.

Eastern Biotech is providing these home testing kits through Genova Diagnostics, USA.

According to Pankaj Sohaney, Manager-Marketing and Business Development, these kits are going to help people for their satisfaction and keep themselves aware of any abnormalities about to happen and can be cured on time. These kits are really important for people of Middle East where life style is changing very fast.

The Human Genome Project has made one of the biggest contributions to the medical diagnosis by revealing an individual's potential susceptibility to specific diseases and analyzing one's risk to various diseased conditions.

Eastern Biotech & Life Sciences introduces, for the first time in the Middle East, the similar highly accurate gene-based 'traffic report' called GENOVATIONS which can clearly pinpoint health risks which previously would have been hidden out-of-sight 'over the horizon'.

The prediction of various diseases is a quite common thing practiced among the people in Europe and USA.

With this new information, user and its physician can chart an alternate route, a smart health "detour" to avoid the health conditions one could to encounter otherwise.

None of us are perfect and neither are our genes. Within one's genetic makeup, there are slight "variations" called Single Nucleotide Polymorphisms (commonly called SNP s, pronounced "snips"). Although they don't cause disease, SNPs are associated with almost every human disease. The "expression" of one's genes into an actual disease isn't inevitable, as many people think. The genomic variations make a person particularly susceptible to a specific type of disease when exposed to certain, often modifiable factors, such as your environment, diet and lifestyle. It isn't the "fate" of any of your genes (even your SNPs) to express themselves as a disease. It is a combination of both your genes and modifiable environment which are responsible for various diseases which we encounter during our life time. And that's where Genovations comes to help us. By taking a simple test, it can inform you and your physician of the specific SNPs you have, making it possible to plan a way "around" your potential risk.

Since it takes your genes and their "environment" to trigger most disease, you can easily take your personalized "alternate route" to avoid the risks, and enjoy a healthier journey in life.

When conditions "run in families" they often have a genetic component. This test can show what specific genomic factors might pose a potential problem for You. If you learn you have a modifiable genetic variation, Your Family Members can also be tested to see whether they have it. The sooner it's known, the sooner you and/or they can begin changing course toward a healthier future.

In primary care practice, Genovations™ will significantly improve healthcare interventions for patients in three major areas:

Predictive assessment

Genetic testing provides the foundation for more effective, timely, and customized preventive strategies based on each patient's unique genetic predisposition. This provides all health-conscious patients with the expanded insight they need to adopt more effective and focused risk-minimizing strategies to improve and protect their health.

Familial associations

Patients with family history of a certain disease can learn if they have inherited a genetic predisposition for this condition and, if so, what they can specifically do to "break the pattern" and better prevent it.

Challenging patients

Genetic testing provides insight into individual genetic variations that can help explain why certain patients may not be responding to clinical interventions that normally produce favorable outcomes.